ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Alloantibodies"

  • 2019 American Transplant Congress

    Human Leukocyte Antigen Class I (HLA-I) Antibodies in Patients Undergoing Liver Transplantation: Implications for Platelet Transfusion Support

    M. Wong1, R. Narra2, M. Selim1, M. A. Zimmerman1, A. Padmanabhan3, J. C. Hong1

    1Div. of Transplant Surgery, Medical College of Wisconsin, Milwaukee, WI, 2Div. of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI, 3Medical College of Wisconsin and BloodCenter of Wisconsin, Milwaukee, WI

    *Purpose: Liver transplantation is a high platelet transfusion (PLT) setting due to the elevated incidence of thrombocytopenia and bleeding. HLA-I antibodies are thought to have…
  • 2019 American Transplant Congress

    Daratumumab for Treatment of Antibody-Mediated Rejection in a Kidney Transplant Recipient

    S. C. Jordan1, R. Vescio2, M. Toyoda3, N. Ammerman1, E. Huang1, A. Peng1, S. Sethi1, R. Najjar1, K. Lim1, A. Vo1

    1Comprehensive Transplant Center, Cedars-Sinai Medical Ctr, Los Angeles, CA, 2Cedars-Sinai Medical Ctr, Los Angeles, CA, 3Transplant Immunology Lab, Cedars-Sinai Medical Ctr, Los Angeles, CA

    *Purpose: Antibody-Mediated Rejection (ABMR) is a severe form of rejection mediated by B-cells, plasma cells and antibodies. The consequences to the patients with ABMR are…
  • 2019 American Transplant Congress

    Not All Donor-Specific Antibodies Are Equal: Predictors of Risk of Chronic Lung Allograft Dysfunction

    C. J. Iasella1, C. R. Ensor2, M. Marrari3, M. Mangiola3, C. A. Moore1, M. R. Morrell4, J. Pilewski4, J. F. McDyer4, A. Zeevi3

    1Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, PA, 2Florida Hospital Transplant Institute, AdventHealth Orlando, Orlando, FL, 3Pathology, University of Pittsburgh, Pittsburgh, PA, 4Medicine, University of Pittsburgh, Pittsburgh, PA

    *Purpose: Donor-specific HLA antibodies (DSA) have been previously associated with chronic lung allograft dysfunction (CLAD). However, the DSA characteristics that predict risk of CLAD are…
  • 2019 American Transplant Congress

    Use Of Perirenal Adipose Tissue As A Source Of Donor Cells Allowing Evaluation Of Endothelial Inflammation And Quality Of Expanded Criteria Kidneys

    R. Boissier1, L. Lyonnet2, P. Francois3, M. Meunier4, B. Gondran-Tellier5, T. Legris6, J. Magalon5, C. Picard7, F. Dignat George5, E. Lechevallier8, G. Karsenty8, F. Sabatier9, P. Paul1

    1INSERM 1263, Centre de recherche en cardiovasculaire et nutrition, INSERM, Aix Marseille Univ, Assistance Publique Hopitaux Marseille, Marseille, France, 2Vascular Biology and Hematology department, Assistance publique Hopitaux Marseille (AP-HM), Marseille, France, 3INSERM 1263, Centre de recherche en cardiovasculaire et nutrition, INSERM, Aix Marseille Univ., Marseille, France, 4Nephrology Dialysis and Renal Transplantation Center, AP-HM, Marseille, France, 5INSERM 1263, C2VN, INSERM, Aix Marseille Univ., Marseille, France, 6Nephrology Dialysis and Renal Transplantation Center, AP-HM, Marseille, France, 7Etablissement Français du Sang, Alpes Méditerranée, Marseille, France, 8Urology and Transplantation Unit , AP-HM, Marseille, France, 9INSERM 1263, Centre de recherche en cardiovasculaire et nutrition, INSERM, Aix Marseille Univ, Marseille, France

    *Purpose: Use of expanded-criteria donor (ECD) kidneys is a perspective to overcome organ shortage. Age and donor-related co-morbidy factors are known to affect graft function…
  • 2019 American Transplant Congress

    Cluster Analysis of Microvascular Inflammation in Indication Biopsies Unveils Distinct Pathological and Immunological Phenotypes with Prognostic Implications

    J. Malheiro1, A. Silva1, S. Santos1, S. Tafulo2, L. Martins1, L. Dias1, A. Castro-Henriques1

    1Centro Hospitalar do Porto, Porto, Portugal, 2IPST_Porto, Porto, Portugal

    *Purpose: We aimed to define distinct pathological and immunological clusters of 80 cases of MVI diagnosed in indication biopsies and evaluate their prognostic implications.*Methods: The…
  • 2019 American Transplant Congress

    Platelets Augment Granzyme K Production By Macrophages In Antibody-mediated Rejection

    J. Dhar, K. Keslar, R. Fan, N. Dvorina, W. Baldwin

    Cleveland Clinic Main Campus, Lerner Research Institute, Cleveland, OH

    *Purpose: When antibodies bind to MHC antigens on endothelial cells a cascade of responses is initiated including exocytosis of adhesion molecules followed by attachment and…
  • 2019 American Transplant Congress

    Donor-Derived Cell-Free DNA is Associated Specifically with Antibody Mediated Injury in Patients with Renal Allograft Dysfunction

    B. Obrisca1, C. Blosser2, I. De Castro2, C. Johnson2, B. Sorohan1, L. Sibulesky2, R. Bakthavatsalam2, G. Ismail1, N. Leca2

    1Fundeni Clinical Institute, Bucharest, Romania, 2University of Washington, Seattle, WA

    *Purpose: Donor-derived cell-free DNA (dd-cfDNA) has been proposed as a noninvasive biomarker to differentiate rejection from other types of injury in renal allografts.*Methods: We analyzed…
  • 2019 American Transplant Congress

    Immediate Post Reperfusion In Vivo Transcriptional Responses of Individual Human Renal Allograft Cell Populations to Circulating Anti-Angiotensin II Type I Receptor Antibody

    C. M. Castro -Rojas1, N. Salomonis2, K. Chetal2, R. R. Alloway3, E. Woodle3, D. A. Hildeman1

    1Immunobiology, Cincinnati Children's Hospital, Cincinnati, OH, 2Biomedical Informatics, Cincinnati Children's Hospital, Cincinnati, OH, 3Transplantation, University of Cincinnati College of Medicine, Cincinnati, OH

    *Purpose: Pre-existing anti-angiotensin II type I receptor (AT1R) antibodies can be a significant driver of allograft rejection. Indeed, prior work has shown that AT1R antibodies…
  • 2019 American Transplant Congress

    Costimulation Blockade Modulates Humoral Responses in Highly Sensitized Transplant Recipients

    J. Kwun, B. Ezekian, P. Schroder, M. Manook, J. Yoon, M. Mulvihill, K. Freischlag, J. Yi, S. Knechtle

    Surgery, Duke Transplant Center, Durham, NC

    *Purpose: Broad human leukocyte antigen sensitization is a significant barrier to successful solid organ transplantation. Sensitized patients have poor access to donor organs, high wait…
  • 2019 American Transplant Congress

    Increasing Net Immunosuppression after BK Viremia

    L. Cotiguala, A. Masood, J. Park, A. Naik

    University of Michigan, Ann Arbor, MI

    *Purpose: BK viremia is associated with inferior kidney allograft outcomes. Typical treatment involves reduction in immunosuppression. However reduction in immunosuppression is also likely to lead…
  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 40
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences